TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 80 filers reported holding TERNS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,424,169 | -57.3% | 283,135 | -25.8% | 0.00% | – |
| Q2 2023 | $3,339,131 | -55.4% | 381,615 | -39.6% | 0.00% | -100.0% |
| Q1 2023 | $7,480,000 | +60772.4% | 631,746 | -47.7% | 0.00% | -50.0% |
| Q4 2022 | $12,288 | -99.8% | 1,207,151 | +31.3% | 0.00% | +100.0% |
| Q3 2022 | $5,413,000 | +270550.0% | 919,042 | +95335.3% | 0.00% | – |
| Q2 2022 | $2,000 | -92.9% | 963 | -89.7% | 0.00% | – |
| Q1 2022 | $28,000 | -46.2% | 9,367 | +25.8% | 0.00% | – |
| Q4 2021 | $52,000 | -5.5% | 7,444 | +41.7% | 0.00% | – |
| Q3 2021 | $55,000 | -60.7% | 5,254 | -54.0% | 0.00% | – |
| Q2 2021 | $140,000 | -73.0% | 11,419 | -51.5% | 0.00% | – |
| Q1 2021 | $518,000 | – | 23,536 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |